A-to-I miR-378a-3p editing can prevent melanoma progression via regulation of PARVA expression

Area of Science:

• Molecular Biology
• Oncology
• RNA Biology

Background:

• Metastatic melanoma exhibits reduced ADAR1 expression, impairing microRNA (miRNA) A-to-I editing.
• The specific impact of miRNA editing on melanoma progression and metastasis remains largely unknown.

Purpose of the Study:

• To investigate the role and mechanism of microRNA editing in melanoma metastasis.
• To determine the function of edited miR-378a-3p in melanoma progression.

Main Methods:

• Analysis of A-to-I editing status of miR-378a-3p in metastatic and non-metastatic melanoma cells.
• In vivo metastasis assays using edited and wild-type miR-378a-3p.
• Assessment of PARVA oncogene expression following miR-378a-3p editing.

Main Results:

• miR-378a-3p undergoes A-to-I editing exclusively in non-metastatic melanoma cells.
• Edited miR-378a-3p targets the 3'-UTR of the PARVA oncogene, suppressing its expression.
• Edited miR-378a-3p effectively inhibits melanoma metastasis in vivo, unlike its wild-type form.

Conclusions:

• RNA editing of miR-378a-3p plays a critical role in suppressing melanoma metastasis.
• The edited form of miR-378a-3p acts as a tumor suppressor by inhibiting the PARVA oncogene.